Bottom line
What is PCODX's expense ratio?
PCODX's expense ratio is 1.72%, or about $172 a year on every $10,000 invested. That is more expensive than 87% of large blend funds we track (median 0.83%). It has no front-end sales load. Its expense ratio includes a 1% 12b-1 marketing fee.
Updated Apr 29, 2026
PCODX fee table
| Net expense ratio | 1.72% |
|---|---|
| Gross expense ratio | 1.76% |
| Management fee | 0.61% |
| 12b-1 (distribution) fee | 1% |
| Other expenses | 0.15% |
| Fee waiver / reimbursement | -0.04% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Apr 29, 2026
What PCODX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PCODX | $275 | $546 | $946 | $1,760 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.72% expense ratio costs roughly $89,500 in lost growth, versus about $46,700 for the median large blend fund (0.83%).
Cheaper alternatives to PCODX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.